Summit Securities Group’s Hims & Hers Health HIMS Stock Holding History

Summit Securities Group’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,560	Closed	-$37.7K	–	923
2024 Q4	$37.7K	Buy	+1,560	New	+$38.6K	0.01%	313
2023 Q1	–	Sell	-14,349	Closed	-$92K	–	1024
2022 Q4	$92K	Buy	+14,349	New	+$81.7K	﹤0.01%	611

Other funds holding HIMS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SIM

SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return

Summit Securities Group's HIMS Position: Q1 2025 in Review

Summit Securities Group sold out of Hims & Hers Health (HIMS) in Q1 2025, closing a stake of 1,560 shares — an estimated $37.7K sold.

Summit Securities Group first reported a position in HIMS in Q4 2022 and held it in 2 quarters. The position peaked at $92K in Q4 2022. 429 funds tracked by Wall St. Rank hold HIMS as of Q1 2025.

Summit Securities Group reported no remaining Hims & Hers Health position as of Q1 2025 after selling out during the quarter.
Summit Securities Group sold 1,560 Hims & Hers Health shares in Q1 2025, an estimated $37.7K.
Summit Securities Group first reported a position in Hims & Hers Health in Q4 2022 and held it in 2 quarters.
Summit Securities Group's Hims & Hers Health position peaked at $92K in Q4 2022.
429 funds tracked by Wall St. Rank held Hims & Hers Health as of Q1 2025.

Based on Summit Securities Group's 13F filing for Q1 2025, filed 13 May 2025.